Non-Invasive Nasal Discharge Fluid and Other Body Fluid Biomarkers in Alzheimer’s Disease

The key to current Alzheimer’s disease (AD) therapy is the early diagnosis for prompt intervention, since available treatments only slow the disease progression. Therefore, this lack of promising therapies has called for diagnostic screening tests to identify those likely to develop full-blown AD. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Da Hae, Son, Gowoon, Kwon, Oh-Hoon, Chang, Keun-A, Moon, Cheil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330777/
https://www.ncbi.nlm.nih.gov/pubmed/35893788
http://dx.doi.org/10.3390/pharmaceutics14081532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330777/
https://www.ncbi.nlm.nih.gov/pubmed/35893788
http://dx.doi.org/10.3390/pharmaceutics14081532

Ejemplares similares